Items where authors include "Lobo, A."

Article

Lindsay, J.O. orcid.org/0000-0003-3353-9590, Hind, D. orcid.org/0000-0002-6409-4793, Swaby, L. orcid.org/0000-0001-9443-7681 et al. (30 more authors) (2024) Autologous stem cell transplantation with low-dose cyclophosphamide to improve mucosal healing in adults with refractory Crohn’s disease: the ASTIClite RCT. Efficacy and Mechanism Evaluation, 11 (3). ISSN 2050-4365

Lindsay, J.O., Hind, D. orcid.org/0000-0002-6409-4793, Swaby, E. orcid.org/0000-0001-9443-7681 et al. (30 more authors) (2024) Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn’s disease (ASTIClite): an open-label, multicentre, randomised controlled trial. The Lancet Gastroenterology and Hepatology. ISSN 2468-1253

Sheldon, E.M. orcid.org/0000-0002-1927-471X, Lillington, G., Simpson, K. et al. (11 more authors) (2022) Development of an inflammatory bowel disease (IBD) Patient‐Reported Experience Measure (PREM): A patient‐led consensus work and ‘think aloud’ study for a quality improvement programme. Health Expectations. ISSN 1369-6513

Coates, E. orcid.org/0000-0002-2388-6102, Wickramasekera, N. orcid.org/0000-0002-6552-5153, Barr, A. orcid.org/0000-0002-7990-7451 et al. (10 more authors) (2022) Patient preferences and current practice for adults with steroid-resistant ulcerative colitis: POPSTER mixed-methods study. Health Technology Assessment, 26 (41). ISSN 1366-5278

Ruiz-Casas, L., Evans, J., Rose, A. et al. (12 more authors) (2021) The LUCID study: living with ulcerative colitis; identifying the socioeconomic burden in Europe. BMC Gastroenterology, 21 (1). 456. ISSN 1471-230X

Brayne, C.E., Barnes, L.E., Breteler, M.M.B. et al. (17 more authors) (2020) Dementia research fit for the planet : reflections on population studies of dementia for researchers and policy makers alike. Neuroepidemiology, 54 (2). pp. 1-14. ISSN 0251-5350

Snowden, J.A. orcid.org/0000-0001-6819-3476, Hawkey, C., Hind, D. orcid.org/0000-0002-6409-4793 et al. (17 more authors) (2019) Autologous stem cell transplantation in refractory Crohn’s disease – low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study. BMC Gastroenterology, 19 (1). 82. ISSN 1471-230X

Assadsangabi, A., Evans, C.A. orcid.org/0000-0003-4356-9216, Corfe, B.M. orcid.org/0000-0003-0449-2228 et al. (1 more author) (2019) Application of Proteomics to inflammatory bowel disease research: Current status and future perspectives. Gastroenterology Research and Practice, 2019. 1426954. ISSN 1687-6121

Snowden, J.A. orcid.org/0000-0001-6819-3476, Sharrack, B., Akil, M. et al. (5 more authors) (2018) Autologous haematopoietic stem cell transplantation (aHSCT) for severe resistant autoimmune and inflammatory diseases - a guide for the generalist. Clinical Medicine, 18 (4). pp. 329-334. ISSN 1470-2118

Sahnan, K., Tozer, P., Adegbola, S. et al. (17 more authors) (2018) Developing a core outcome set for fistulising perianal Crohn’s disease. Gut. ISSN 0017-5749

Tappenden, P. orcid.org/0000-0001-6612-2332, Ren, S., Archer, R. et al. (6 more authors) (2016) A Model-Based Economic Evaluation of Biologic and Non-Biologic Options for the Treatment of Adults with Moderately-to-Severely Active Ulcerative Colitis after the Failure of Conventional Therapy. PharmacoEconomics, 34 (10). pp. 1023-1038. ISSN 1170-7690

Rafia, R. orcid.org/0000-0002-6914-1990, Scope, A. orcid.org/0000-0003-1604-1758, Harnan, S. orcid.org/0000-0002-9318-9206 et al. (3 more authors) (2016) Vedolizumab for Treating Moderately to Severely Active Crohn’s Disease After Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. ISSN 1170-7690

Archer, R., Tappenden, P., Ren, S. et al. (8 more authors) (2016) Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model. Health Technoogyl Assessment, 20. 39. ISSN 1366-5278

Essat, M., Tappenden, P., Ren, S. et al. (5 more authors) (2015) Vedolizumab for the Treatment of Adults with Moderate-to-Severe Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. ISSN 1170-7690

Proceedings Paper

Sheldon, E. orcid.org/0000-0002-1927-471X, Roman, S., Bursnall, M. et al. (5 more authors) (2023) P284 Assessing patient experience in an inflammatory bowel disease service. Can we measure an effect from socioeconomic deprivation – experience from the AWARE-IBD programme? In: ECCO 2023 Abstracts: Poster Presentations. 18th Congress of European Crohn´s and Colitis Organisation (ECCO 2023), 01-04 Mar 2023, Copenhagen, Denmark. European Crohn's and Colitis Organisation , Copenhagen .

Sheldon, E. orcid.org/0000-0002-1927-471X, Roman, S., Randall, K. et al. (4 more authors) (2023) P670 “What Matters To You?” – How do patient views compare with a patient experience framework and UK national standards of care? In: ECCO 2023 Abstracts: Poster Presentations. 18th Congress of European Crohn´s and Colitis Organisation (ECCO 2023), 01-04 Mar 2023, Copenhagen, Denmark. European Crohn's and Colitis Organisation .

Sheldon, E., Roman, S., Bursnall, M. et al. (6 more authors) (2023) P284 Assessing patient experience in an inflammatory bowel disease service. Can we measure an effect from socioeconomic deprivation – experience from the AWARE-IBD programme? In: Journal of Crohn's and Colitis. 18th Congress of European Crohn´s and Colitis Organisation (ECCO 2023), 01-04 Mar 2023, Copenhagen, Denmark. Oxford University Press (OUP) , i431-i432.

Sheldon, E. orcid.org/0000-0002-1927-471X, Roman, S., Randall, K. et al. (4 more authors) (2023) P670 “What Matters To You?” – How do patient views compare with a patient experience framework and UK national standards of care? In: Journal of Crohn's and Colitis. 18th Congress of European Crohn´s and Colitis Organisation (ECCO 2023), 01-04 Mar 2023, Copenhagen, Denmark. Oxford University Press (OUP) , i801-i802.

Lindsay, J., Din, S., Hawkey, C. et al. (11 more authors) (2021) OFR-9 An RCT of autologous stem-cell transplantation in treatment refractory Crohn’s disease (low-intensity therapy evaluation): ASTIClite. In: Gut. BSG Annual Meeting 2021, 08-12 Nov 2021, Virtual conference. BMJ Publishing Group Ltd and British Society of Gastroenterology , a4-a4.

Barr, A., Coates, E., Wickramasekera, N. orcid.org/0000-0002-6552-5153 et al. (9 more authors) (2021) P96 Factors influencing treatment preferences in steroid resistant ulcerative colitis – a qualitative interview study. In: Gut. BSG Campus, 21-29 Jan 2021, Virtual. BMJ Publishing Group , a90-a91.

Coates, E., Barr, A., Totton, N. orcid.org/0000-0002-1900-2773 et al. (9 more authors) (2021) P97 Management of steroid resistant ulcerative colitis – a national survey of UK practice. In: Gut. BSG Campus, 21-29 Jan 2021, Virtual. BMJ Publishing Group Ltd , a91-a91.

Marshall, J., Baker, D., Lee, M. orcid.org/0000-0001-9971-1635 et al. (3 more authors) (2017) Assessing internet based information used to aid patient decision making in surgery for perianal Crohn's fistula. In: Techniques in Coloproctology. East Midlands Surgical Society Summer Meeting, Leicester, UK. Springer , S428-S428.